CNTB · NASDAQ
Connect Biopharma Holdings (CNTB) Stock Price & Fundamentals
Connect Biopharma Holdings (CNTB) closed at $633.29 on Oct 9, 2026, down 0.29% from the previous close of $635.16.
Share price, past year
1Y +2.17%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $633.29 |
| Sep 30, 2026 | $628.70 |
| Aug 31, 2026 | $648.65 |
| Jul 31, 2026 | $650.43 |
| Jun 30, 2026 | $666.58 |
| May 29, 2026 | $688.97 |
| Apr 30, 2026 | $716.89 |
| Mar 31, 2026 | $678.96 |
| Feb 27, 2026 | $611.24 |
| Jan 30, 2026 | $612.16 |
| Dec 31, 2025 | $567.89 |
| Nov 28, 2025 | $594.14 |
| Oct 31, 2025 | $612.71 |
Key statistics
- Market cap
- $39.88B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.19
- Revenue (TTM)
- $2.95M
- Net income (TTM)
- −$68.99M
- Shares outstanding
- 63M
- Dividend yield
- —
- 52-week range
- $560.86 – $733.37
Connect Biopharma Holdings's market cap is $39.88B, based on a share price of $633.29 and 63M shares outstanding as of Jun 30, 2026.
Financials
Connect Biopharma Holdings reported revenue of $64.00K for fiscal 2025, down 99.75% from fiscal 2024.
Connect Biopharma Holdings reported a net loss of $55.48M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $64.00K | −99.8% | −$55.48M | −86,687.5% | −$1.00 | −$51.64M |
| FY2024ended Dec 31, 2024 | $26.03M | — | −$15.63M | −60.0% | −$0.28 | −$24.36M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$62.11M | — | −$1.13 | −$47.82M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.77M | −$17.28M | −$0.27 |
| Q1 FY2026ended Mar 31, 2026 | $169.00K | −$19.40M | −$0.34 |
| Q4 FY2025ended Dec 31, 2025 | $0.00 | −$15.11M | −$0.27 |
| Q3 FY2025ended Sep 30, 2025 | $16.00K | −$17.20M | −$0.31 |
| Q2 FY2025ended Jun 30, 2025 | $48.00K | −$12.90M | −$0.23 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$10.27M | −$0.19 |
| Q3 FY2024ended Sep 30, 2024 | $1.22M | −$12.88M | −$0.23 |
| Q2 FY2024ended Jun 30, 2024 | $24.12M | — | — |
Company profile
- Name
- Connect Biopharma Holdings Ltd
- Ticker
- CNTB
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 3580 Carmel Mountain Road, Suite 200, San Diego, CA 92130
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001835268
Recent SEC filings
- Sep 30, 2026
- Sep 15, 2026
- Aug 12, 2026
- Aug 12, 2026
- May 12, 2026
- May 12, 2026
- Apr 23, 2026
- Mar 31, 2026
Frequently asked questions
What is Connect Biopharma Holdings's stock price?
Connect Biopharma Holdings (CNTB) closed at $633.29 on Oct 9, 2026, down 0.29% from the previous close of $635.16.
What is Connect Biopharma Holdings's market cap?
Connect Biopharma Holdings's market cap is $39.88B, based on a share price of $633.29 and 63M shares outstanding as of Jun 30, 2026.
How much revenue does Connect Biopharma Holdings make?
Connect Biopharma Holdings reported revenue of $64.00K for fiscal 2025, down 99.75% from fiscal 2024.
Does Connect Biopharma Holdings pay a dividend?
Connect Biopharma Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Connect Biopharma Holdings Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures